
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp. is poised for robust growth, particularly within its Hospice segment, which is expected to achieve revenue growth at the high end of 5-7%, supported by stronger admissions and improved leadership strategies. The company's Home Health segment is also showing positive performance with a 1.6% year-over-year revenue increase, driven by optimized case loads and solid operational efficiencies. Additionally, the upward revisions in consensus estimates for 2025, including an 11% increase in revenue projections, indicate a strong market response to Addus's strategic initiatives and potential for further acquisitions to bolster revenue growth targets.
Bears say
Addus HomeCare Corp's stock outlook is negatively influenced by a persistent decline in its Home Health segment, where same-store volumes recorded a year-over-year decrease of -3.2% and new admissions fell by -6.2%. Revenue from Home Health was also disappointing, coming in -2.7% below projections, primarily due to lower volumes despite a partial offset from higher rates. Furthermore, the company's expectation of sequential gross margin compression and lowered adjusted EBITDA estimates for 2025-2027 further underscores concerns regarding its financial stability and growth prospects.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares